Unilife's Bolus Injector Platform Targeted by Global Pharmaceutical Company for Use in Multi-Dr... ( YORK Pa. Nov. 8 2012 /- Uni...)

Unilife's Bolus Injector Platform Targeted by Global Pharmaceutical Company for Use in Multi-Drug Program

Date:11/8/2012

YORK, Pa., Nov. 8, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: UNIS; ASX: UNS) today announced that its Precision-Therapy™ platform of bolus injection systems has been selected by a global pharmaceutical company to enter the next stage of collaboration as its preferred choice for long-duration subcutaneous drug delivery.

Unilife has been advised that the global pharmaceutical company (the "Customer") is targeting more than five pipeline injectable drugs for use with the Precision-Therapy platform of bolus injectors (wearable, disposable pumps). The first of these target drugs identified by the Customer is in Phase III clinical trials.

Unilife has recently commenced the initial supply of its Precision-Therapy devices to the Customer. Initial revenues will be generated by Unilife during the current fiscal year as it supports the immediate needs of the Customer under this partnership program.

Unilife expects to enter into a development agreement with the Customer during the current fiscal year to customize Precision-Therapy devices for use in the first target drug's upcoming human clinical trials. Unilife expects the first of these development agreements to generate in excess of $10 million in revenue over an 18 to 24 month period. Unilife expects to successively enter into a series of additional development agreements with similar terms relating to the other target drugs.

Unilife further expects that it will begin commercial supply of Precision-Therapy bolus injectors to the Customer in 2015 to support the anticipated market launch of the first target drug. Commercial supply contracts for each targeted drug under the program are expected to have an initial term of seven years. Based upon indicated customer requirements for the first drug candidate, Unilife expects to generate commercial revenues of
'/>"/>

SOURCE Unilife Corporation
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement with Teva
2. Bausch + Lomb Product, Platform and Pipeline Innovations on Display at the Annual Meeting of the American Academy of Ophthalmology
3. Greenphires ClinCard Technology Platform selected by top 5 pharmaceutical company for long-term global clinical trial
4. Advantages of Pressure BioSciences PCT Platform Highlighted at a Recent International Scientific Conference Focused on the Role of Proteins in the Cause, Prevention, and Treatment of Disease
5. CombiMatrix Corporation Selects Cartagenia BENCHlab CNV Platform to Bolster Expanded Lab Operations
6. Keynote Presentation at Upcoming International Microbiology & Genomics Meeting to Highlight Ability of Pressure BioSciences Patented PCT Platform to Improve Testing for Biological Threat Organisms, Human Infectious Diseases, and Contaminated Food P
7. Innovations in Drug Delivery - Broad-based Proprietary Technology Platforms to Address Delivery Efficiency and Improve Patient Compliance
8. Lincor Solutions Launches Next Generation Bedside Point of Care Computing Platform at HIMSS AsiaPac 12
9. Indegene Introduces TrialPedia 2.0 with Advantage Insights, Making It the Most Comprehensive Clinical Trial Analytics and Decision Support Platform for the Pharma Industry
10. Absorption Systems announces novel test platform for interactions with the BCRP transporter
11. Pressure BioSciences Patented PCT Platform Shown to Significantly Improve Protein and DNA Detection in Multiple Studies

Post Your Comments:

(Date:5/24/2013)... Heska Corporation (NASDAQ: HSKA, "Heska" or the "Company"), a ... that Dr. Robert Grieve , the Company,s ... , executive vice president and chief financial officer, will ... being held May 30, 2013 in New York ... The Company,s presentation is scheduled to begin at 1:30 ...

(Date:5/24/2013)... 24, 2013 Sinovac Biotech Ltd. (NASDAQ: ... products in China , announced ... of Sinovac, obtained the Certificate of Good Manufacturing ... China State and Food Administration (CFDA) for its ... and its Changping filing and packaging facility. The ...

(Date:5/23/2013)... Inc. (Vanda) (NASDAQ: VNDA ) today announced that ... of the Year by the Tech Council of ... 25 th Annual Tech Awards Celebration held in ... the leaders and innovators in the technology and life science ... regions. "We are deeply honored to receive ...

Breaking Medicine Technology:Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2 Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 2 Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 3 Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2

[0] Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference [0] Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines [0] Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland

... -,Phytopharm plc (LSE: PYM) ("Phytopharm" or the ... reverses the,changes in the area of the ... be presented by Dr Jonathan Brotchie, an,internationally ... International Congress of Parkinson's Disease and Movement,Disorders' ...

... the Companies' Novel Heat Shock Protein 90 ... Biological,Activity , CAMBRIDGE, Mass. and GAITHERSBURG, Md., ... Inc. (Nasdaq:INFI) and,MedImmune, Inc. (Nasdaq:MEDI) today announced ... trial of the companies' heat shock,protein 90 ...

Cached Medicine Technology:Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 2 Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 3 Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 4 Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 5 Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 2 Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 3 Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 4 Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 5 Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 6 Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 7

Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting

(Date:5/25/2013)... According to a new market ... published by MarketsandMarkets is expected to reach $544.02 ... which analyzes and studies the major market drivers, ... and Rest of the World. , Browse:, ... 87 Figures , 175 ...

(Date:5/25/2013)... Vancouver, BC (PRWEB) May 25, 2013 ... of the most beautiful and powerful women that ever ... was felt by some of the most powerful men ... used many beauty remedies to keep her skin glowing ... treatments made with bees- wax, maringa oil and cyprus ...

(Date:5/25/2013)... Los Angeles, CA (PRWEB) May 25, 2013 ... will grow at an average annual rate of 28.7% ... growth of 17.9% in 2013. From 2002 and 2008, no ... analyst Kevin Culbert, causing relatively modest growth during that period. ... (FDA) has approved six new products. This factor contributed to ...

(Date:5/25/2013)... 25, 2013 Ayurveda is the ... wisdom of life". While a medical science, its scope enters ... consciousness. Its fundamental philosophy is that disease is the end ... order to re-establish optimal health, one must discover where we ... style which brings us back into perfect harmony. , The ...

(Date:5/25/2013)... Flagstaff, Arizona (PRWEB) May 25, 2013 The ... Rehabilitation Center, their parents, and the B2B staff all came ... While everyone enjoyed an array of Indian Cuisine, the residents ... the company, for helping them on their road to recovery, ... started the Drug and Alcohol center in 2010 after realizing ...

Breaking Medicine News(10 mins):Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 2 Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 3 Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 4 Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2 Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3 Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 2 Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 3 Health News:Fundamentos de Ayurveda in Mexico (Ayurvedic Principles) Offered by Escuela de Ayurveda de California 2 Health News:Back2Basics Drug and Alcohol Rehabilitation Center Celebrates Their 3rd Anniversary 2

[0] Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets [0] The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician [0] Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld [0] Fundamentos de Ayurveda in Mexico (Ayurvedic Principles) Offered by Escuela de Ayurveda de California [0] Back2Basics Drug and Alcohol Rehabilitation Center Celebrates Their 3rd Anniversary

... , WEDNESDAY, Nov. 2 (HealthDay News) -- A new drug ... to improved lung function and fewer symptoms in people with ... -- is the first to halt the underlying processes that ... build up in the lungs and the pancreas and can ...

... WEDNESDAY, Nov. 2 (HealthDay News) -- The death toll in ... farm has reached 29, with another 139 people sickened in ... recently that the outbreak appeared to have been caused by ... Sept. 22 and 23 by federal and state authorities at ...

... not effectively prepare firefighters for the range of ... human factors/ergonomics researchers Michael R. Baumann, Carol L. ... 2011 Human Factors article, "Phased Training ... the authors assess the value of current scenario-based ...

... , WEDNESDAY, Nov. 2 (HealthDay News) -- Researchers using ... far determined that it was a child of a wealthy ... The mummy, owned by the Spurlock Museum at ... 1990, and more scans with updated CT technology this year. ...

... (HealthDay News) -- The legalization of medical marijuana in ... the availability and appeal of the drug among youth, ... the study, Rhode Island Hospital researchers examined adolescent marijuana ... 2009. Rhode Island legalized medical marijuana in 2006. ...

... from the University of Notre Dame,s Keck Center ... are joining forces to use a new medical ... patients.Researchers at the Keck Center investigate how the ... inflammatory diseases like sepsis, atherosclerosis and asthma. In ...

Cached Medicine News:Health News:New Drug Targets Underlying Cause of Cystic Fibrosis 2 Health News:New Drug Targets Underlying Cause of Cystic Fibrosis 3 Health News:New Drug Targets Underlying Cause of Cystic Fibrosis 4 Health News:Death Toll From Listeria Outbreak Hits 29 2 Health News:Death Toll From Listeria Outbreak Hits 29 3 Health News:Current training programs may not prepare firefighters to combat stress 2 Health News:Modern Technology Reveals Clues From Egyptian Mummy 2 Health News:Univesity of Notre Dame researchers form new partnership to help trauma patients 2

New Drug Targets Underlying Cause of Cystic Fibrosis Death Toll From Listeria Outbreak Hits 29 Current training programs may not prepare firefighters to combat stress Modern Technology Reveals Clues From Egyptian Mummy Teen Pot Use Unaffected by Medical Marijuana Law: Study Univesity of Notre Dame researchers form new partnership to help trauma patients

High sensitive, specific one step immunochromatographic assay for human infectious disease...

Span Diagnostics Limited...

Malaria (P. fal.) Ag Rapid Test...

OptiMAL is a malaria test, for diagnosis and therapy control of an infection by Plasmodium species (Malaria)....

Medicine Products:

Malaria P.v. Ab Test Parahit f Malaria Dipstick/Device Malaria (P. fal.) Ag Rapid Test OptiMAL Malaria Test